Observational Non-interventional Study (Anwendungsbeobachtung) With Telmisartan in High-risk Hypertensives
TOP -Study Telmisartan - Therapy of Hypertension and Life-style Changes in Cardiovascular Risk Patients
Sponsor: Boehringer Ingelheim
This observational or N/A phase trial investigates Hypertension and Obesity and is currently completed. Boehringer Ingelheim leads this study, which shows 8 recorded versions since 2007 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
8 versions recorded-
Nov 2025 — Present [monthly]
Completed
-
Sep 2025 — Nov 2025 [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
▶ Show 3 earlier versions
-
Jun 2018 — Jan 2021 [monthly]
Completed
-
Apr 2018 — Jun 2018 [monthly]
Completed
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Completed NA
First recorded
Jan 2007
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Boehringer Ingelheim
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Aachen, Germany , Aalen, Germany , Aarbergen, Germany , Abstatt, Germany , Achern, Germany , Adendorf, Germany , Aham, Germany , Ahaus, Germany , Ahlen, Germany , Ahorn, Germany and 1249 more locations